Healthcare / Medical DevicesUpdated 2026-05-09 17:08 UTC

NVCR stock hub

NovoCure Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NVCRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.1B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

NVCR

In the news

Latest news · NVCR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-50

P25 -105.6P50 -46.5P75 -3.1

ROIC-131.1

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NVCR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001645113
Company name	NovoCure Limited
Country	Switzerland
Country code	US
Cusip	G6674U108
Employees	1,605
Employees Change	117%
Employees Change Percent	7.86
Enterprise value	$1.9B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2015-10-02
Isin	JE00BYSS4X48
Last refreshed	2026-05-09
Market cap	$2.1B
Market cap category	Mid-Cap
Price	$17.89
Price currency	USD
Rev Per Employee	420,195.64x
Sector	Healthcare
Sic	3841
Symbol	NVCR
Website	https://www.novocure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.35%
EV Sales Forward	2.59x
EV/Sales	2.78x
FCF yield	-2.32%
P/B ratio	6.27x
P/S ratio	3.07x
PS Forward	2.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-26.71%
EBITDA Margin	-24.65%
Gross margin	75.45%
Gross Profit	$508.8M
Gross Profit Growth	5.85%
Gross Profit Growth Q	16.01%
Gross Profit Growth3 Y	7.79%
Gross Profit Growth5 Y	3.95%
Net Income	$-173M
Net Income Growth Years	2%
Pretax Margin	-25.98%
Profit Margin	-25.66%
Profit Per Employee	$-107,817
ROA	-11.06
Roa5y	-7.44
ROCE	-31.59
ROE	-49.96
Roe5y	-34.39
ROIC	-131.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.58%
Cagr1y	7.45%
Cagr3y	-35.99%
Cagr5y	-37.82%
EPS Growth Years	2
Revenue Growth	8.48x
Revenue Growth Q	12.3x
Revenue Growth Quarters	10x
Revenue Growth Years	2x
Revenue Growth3 Y	8.88x
Revenue Growth5 Y	5.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.66
Assets	$787.9M
Cash	$432M
Current Assets	$631.7M
Current Liabilities	$217.6M
Debt	$234.9M
Debt Equity	$0.71
Equity	$330.7M
Interest Coverage	-9.18
Liabilities	$457.2M
Long Term Assets	$156.3M
Long Term Liabilities	$239.6M
Net Cash	$197.1M
Net Cash By Market Cap	$9.51
Net Cash Growth	-15.21%
Net Debt Equity	$-0.6
Tangible Book Value	$330.7M
Tangible Book Value Per Share	$2.86
WACC	8.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.9
Inventory Turnover	3.99
Net Working Capital	$-17.9M
Quick ratio	2.66
Working Capital	$414.1M
Working Capital Turnover	$1.77

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.55%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	42.1%
1Y total return	7.45%
200-day SMA	12.57
3Y total return	-73.78%
50-day SMA	12.65
50-day SMA vs 200-day SMA	50over200
5Y total return	-90.7%
All Time High	232.8
All Time High Change	-92.31%
All Time High Date	2021-06-24
All Time Low	5.95
All Time Low Change	200.67%
All Time Low Date	2016-10-31
ATR	0.98
Beta	0.9
Beta1y	1.31
Beta2y	1.46
Ch YTD	38.36
High	18.19
High52	20.06
High52 Date	2025-05-29
High52ch	-10.82%
Low	16.85
Low52	9.82
Low52 Date	2026-02-09
Low52ch	82.18%
Ma50ch	41.38%
Premarket Change Percent	0.06
Premarket Price	$16.84
Premarket Volume	11,036
Price vs 200-day SMA	42.31%
RSI	74.41
RSI Monthly	46.75
RSI Weekly	65.35
Sharpe ratio	0.41x
Sortino ratio	0.73
Total Return	-3.55%
Tr YTD	38.36
Tr1m	72.85%
Tr1w	7.64%
Tr3m	76.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	2
Analyst Price Target Top	$20.5
Analyst Ratings	Buy
Analyst Ratings Top	Hold
Earnings EPS Estimate	$-0.49
Earnings Revenue Estimate	167,803,712x
Earnings Revenue Estimate Growth	8.26x
Operating Income	$-180.1M
Operating margin	-26.71
Price target	$27.29
Price Target Change	$52.54
Price Target Change Top	$14.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,324,427%
Float Percent	84.03%
Net Borrowing	-460,966,000
Shares Insiders	8.6%
Shares Institutions	77.2%
Shares Out	115,820,940
Shares Qo Q	1.7%
Shares Yo Y	3.55%
Short Float	8.95%
Short Ratio	7.35
Short Shares	7.52

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-186.4M
Average Volume	1,821,635.5x
Bv Per Share	2.86
CAPEX	$-21.2M
Ch10y	42.1
Ch1m	72.85
Ch1w	7.64
Ch1y	7.45
Ch3m	76.43
Ch3y	-73.78
Ch5y	-90.7
Ch6m	63.83
Change	6.3%
Change From Open	5.86
Close	16.83
Days Gap	0.42
Depreciation Amortization	13,930,000
Dollar Volume	42,522,955.7
Earnings Date	2026-04-30
Earnings Time	bmo
EBIT	$-180.1M
EBITDA	$-166.2M
EPS	$-1.54
F Score	3
FCF	$-48.1M
FCF EV Yield	-2.56x
FCF Per Share	$-0.42
Financing CF	-456,756,000
Fiscal Year End	December
Founded	2,000
Income Tax	$-2.2M
Investing CF	451,495,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	12.7
Ma150ch	40.86%
Ma20	13.75
Ma20ch	30.11%
Net CF	-32,107,000
Next Earnings Date	2026-07-23
Open	16.9
Optionable	Yes
Position In Range	77.61
Post Close	17.89
Postmarket Change Percent	-1.62
Postmarket Price	$17.6
Ppne	145,063,000
Pre Close	16.83
Price Date	2026-05-08
Ptbv Ratio	6.27
Relative Volume	1.3x
Revenue	674,414,000x
SBC By Revenue	20.51x
Share Based Comp	138,289,000
Tax By Revenue	-0.32x
Tr6m	63.83%
Volume	2,376,912
Z Score	0.37

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NVCR pay a dividend?

Capital-return profile for this ticker.

Performance

NVCR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NVCR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+77.2%

Float: +84.0% of shares outstanding

Insider ownership

+8.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

NVCR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

74.4

Above 70: short-term overbought

Price vs 200-day MA

+42.3%

50/200-day relationship not available

Beta (5Y)

0.90

Moves roughly with the market

Sharpe ratio

0.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NVCR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current NVCR stock rating?

NovoCure Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full NVCR analysis?

The full report lives at /stocks/NVCR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for NVCR?

The latest report frames NVCR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the NVCR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.